GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
134 hedge funds and large institutions have $1B invested in Genomic Health, Inc. in 2018 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 37 reducing their positions, and 22 closing their positions.
Holders
134
Holders Change
-1
Holders Change %
-0.74%
% of All Funds
3.08%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
25
Increased
47
Reduced
37
Closed
22
Calls
$4.14M
Puts
–
Net Calls
+$4.14M
Net Calls Change
+$1.12M
Top Buyers
1 |
1
Ameriprise
Minneapolis,
Minnesota
|
$47.3M |
2 |
2
Man Group
London,
United Kingdom
|
$8.35M |
3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$12.2M |
4 |
4
State Street
Boston,
Massachusetts
|
$26.2M |
5 |
5
Renaissance Technologies
New York
|
$37M |